ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver"

  • 2015 American Transplant Congress

    Bioengineering Liver Allografts through Organ Scaffold Recellularization

    J. Woodall, J. Langford, C. Klassen, J. Harrison, D. Parsell, U. Dhru, R. Barth, J. LaMattina.

    University of Maryland School of Medicine, Baltimore.

    Bioengineering livers using organ scaffolds offers an approach to increasing allograft availability for end stage liver disease. Recellularized liver scaffolds will require multiple differentiated cell…
  • 2015 American Transplant Congress

    CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment

    R. Hotta,1 M. Ohira,2 T. Matsuura,1 I. Muraoka,1 P. Tryphonopoulos,1 J. Fan,1 A. Tekin,1 H. Ohdan,2 A. Tzakis,3 R. Vianna,1 S. Nishida.1

    1University of Miami, Miami, FL; 2Hiroshima University, Hiroshima, Japan; 3Cleveland Clinic Florida, Weston, FL.

    Background: T-cell depleting strategies have become an integral part of immunosuppressive regimens in organ transplantation. Alemtuzumab is a humanized monoclonal antibody against CD52, a cell-surface…
  • 2015 American Transplant Congress

    Delivery of Heme Oxygenase-1-Cell Penetrating Peptide (HO-1-CPP) Into Hepatocytes, Kupffer and Islet Cells in In Vitro and Ex Vivo Models of Cold Ischemia

    A. Venkatachalam,1 C. Wood,1 Q. Hu,1 I. Alwayn.2

    1Surgery, Dalhousie University, Halifax, NS, Canada; 2Surgery, Pathology, Microbiology & Immunology, Surgical Lead Multi Organ Transplant Program, QEII Health Sciences Center, Dalhousie University, Halifax, NS, Canada.

    In an attempt to increase the number of donor organs available to transplantation extended criteria donor (ECD) organs are more frequently considered. Unfortunately, ECD organs…
  • 2015 American Transplant Congress

    Activated Protein C Treatment Protects Steatotic and Non-Steatotic Livers Under Ischemia–Reperfusion Injury in Different Manner

    A. Matsuda, N. Kuriyama, H. Kato, Y. Azumi, M. Kishiwada, S. Mizuno, M. Usui, S. Isaji.

    Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Mie, Japan.

    Activated protein C (APC) is known to have the cytoprotective effect on liver ischemia–reperfusion injury (IRI) in rat models. However, it is unclear that whether…
  • 2015 American Transplant Congress

    Ischemia-Induced Endoplasmic Reticulum Stress Regulates Autophagy to Determine the Severity of Liver Ischemia Reperfusion Injury

    H. Zhou,1,2 J. Zhu,1 S. Yue,1 R. Busuttil,1 J. Kupiec-Weglinski,1 Y. Zhai.1

    1The Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA; 2Liver Transplant Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

    Both endoplasmic reticulum (ER) stress and autophagy have been implicated in the pathogenesis of ischemia and reperfusion injury (IRI). As essential cellular stress responses against…
  • 2015 American Transplant Congress

    Suboptimal Vaccination Coverage After Liver Transplantation: Opportunity for Improvement

    L. Danziger-Isakov, S. Blum, G. Paulsen, M. Lake, R. Rengering, M. Duncan, J. Zigmond, K. Campbell, J. Bucuvalas.

    Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

    Elimination of vaccine-preventable disease after solid organ transplantation (SOT) has the potential to improve outcomes. We evaluated immunization rates and the impact of directed recommendations…
  • 2015 American Transplant Congress

    Down-Regulation of Autophagy Correlates With Increased Apoptosis in the Kidney, But Not in the Liver, of Brain Dead Rats

    A. van Erp,1 R. Rebolledo,3 P. Ottens,1 J. Pirenne,2 H. Leuvenink,1 J.-P. Decuypere.2

    1Department of Surgery, University Medical Center Groningen, Groningen, Netherlands; 2Department of Microbiology and Immunology, Catholic University Leuven, Leuven, Belgium; 3Department of Surgery, University of Chile, Santiago, Chile.

    Organs from brain dead donors have inferior quality and show higher rejection rates after transplantation compared to living donors. Brain death (BD) in the donor…
  • 2015 American Transplant Congress

    Increased Fibroblast Growth Factor 21 Levels in Biliary Atresia Patients

    D. Li, T. Lu, Y. Shan, C. Shen, X. Hua, M. Zhang, Q. Xia.

    Renji Hospital, Shanghai, China.

    Background: Fibroblast growth factor (FGF)-21, a hormone predominantly secreted by the liver, has recently been reported as a key circulating adipokine involving in metabolic disorders…
  • 2015 American Transplant Congress

    Effect of Fully Laparoscopic Left Hepatectomy on Donor Interest in Living Donor Liver Transplantation (LDLT)

    A. Yegiants, D. Santamour, T. Mansour, J. Pisa, J. Emond, B. Samstein.

    Center for Liver Disease and Transplantation, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY.

    Purpose: Laparoscopy was extended to liver donation to reduce invasiveness and our center has offered selected patients fully laparoscopic procurement since 8/12. We sought to…
  • 2015 American Transplant Congress

    Changing Demographics of HIV+ Liver Transplant Candidates

    C. Durand, S. Gustafson, J. Locke, J. Snyder, B. Shelton, R. Reed, P. MacLennan, S. Mehta, A. Nellore, D. Segev.

    Johns Hopkins University, Baltimore, MD; Scientific Registry of Transplant Recipients (SRTR), Minneapolis Medical Research Foundation, Minneapolis, MN; University of Alabama, Birmingham, Birmingham, AL.

    Liver transplant (LT) is considered a reasonable therapeutic option for certain HIV+ patients with end-stage liver disease (ESLD). As OPTN does not collect HIV status…
  • « Previous Page
  • 1
  • …
  • 47
  • 48
  • 49
  • 50
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences